These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11355603)

  • 1. [Indications and preparations for kidney dialysis].
    Jungers P; Robino C; Choukroun G; Man NK
    Rev Prat; 2001 Feb; 51(4):391-5. PubMed ID: 11355603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patients in pre-dialysis: decision taking and free choice of treatment].
    Sarrias Lorenz X; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():119-22. PubMed ID: 19018749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
    McNulty CA; Bowen JK; Williams AJ
    Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination against Hepatitis B Virus in chronic renal disease patients].
    Franco E; Senatore S; Ruggiero F; Papa R; Zaratti L
    Ig Sanita Pubbl; 2008 Jan; 64(1):131-6. PubMed ID: 18379610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [When to start dialysis. The predialysis patient].
    Triolo G; Savoldi S
    G Ital Nefrol; 2008; 25 Suppl 41():S9-12, discussion S13-20. PubMed ID: 18473314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
    Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
    Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and treatment of hepatitis B in patients on hemodialysis and vaccination of hemodialysis health personnel against hepatitis B].
    Kes P; Slavicek J; Janković N
    Acta Med Croatica; 2005; 59(5):479-82. PubMed ID: 16381247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Should dialysis be for all? Yes indeed!].
    Panzetta G; Grignetti M; Toigo G
    G Ital Nefrol; 2008; 25(3):277-83. PubMed ID: 18473297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modality selection.
    Diaz-Buxo JA
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S112-7. PubMed ID: 11443757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
    Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
    Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease.
    Kuan Y; Hossain M; Surman J; El Nahas AM; Haylor J
    Nephrol Dial Transplant; 2005 Nov; 20(11):2394-401. PubMed ID: 16115853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of dialysis: when?
    Man NK
    Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):1-8. PubMed ID: 1344189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.
    Almond A; Siddiqui S; Robertson S; Norrie J; Isles C
    QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rapid vaccination protocol against hepatitis B in patients with chronic kidney failure].
    Teruel JL; Fernández Lucas M; Mateos ML; Ortuño J
    Nefrologia; 2005; 25(3):338-9. PubMed ID: 16053018
    [No Abstract]   [Full Text] [Related]  

  • 20. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
    Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
    Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.